CYP1A1 MspI polymorphism and cancer susceptibility among Latinos: A meta-analysis

ACS Adonis, 2005, CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water, Xenobiotica, 35, 519, 10.1080/00498250500057310 Barbieri, 2012, Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma, Eur. J. Endocrinol., 166, 241, 10.1530/EJE-11-0843 Barbieri, 2013, Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk, Clin. Endocrinol., 79, 288, 10.1111/cen.12136 Barra, 2007, Polycyclic aromatic hydrocarbons in the South American environment, 1, 10.1007/978-0-387-69163-3_1 Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446 Caceres, 2005, Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions, Eur. J. Epidemiol., 20, 79, 10.1007/s10654-004-1632-9 Canalle, 2004, Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia, Environ. Mol. Mutagen., 43, 100, 10.1002/em.20003 Castaño-Molina, 2009, CYP1A1, CYP2E1 and gastric cancer risk in a high-incidence Colombian population, Acta Biologica Colombiana, 14, 203 Cordero, 2010, Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals, Oncol. Lett., 1, 549, 10.3892/ol_00000097 Cury, 2012, Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk, Mol. Biol. Rep., 39, 1055, 10.1007/s11033-011-0831-1 da Fonte de Amorim, 2002, CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women, Cancer Lett., 181, 179, 10.1016/S0304-3835(02)00058-7 de Andrade Ramos, 2016, Neither self-reported ethnicity nor declared family origin are reliable indicators of genomic ancestry, Genetica, 144, 259, 10.1007/s10709-016-9894-1 Denison, 2003, Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals, Annu. Rev. Pharmacol. Toxicol., 43, 309, 10.1146/annurev.pharmtox.43.100901.135828 DerSimonian, 1986, Meta-analysis in clinical trials, Control. Clin. Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Ding, 2013, CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis, Mol. Biol. Rep., 40, 3483, 10.1007/s11033-012-2423-0 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Fernández, 2011 Gallegos-Arreola, 2008, Distribution of CYP1A1*2A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population, Blood Cells Mol. Dis., 41, 91, 10.1016/j.bcmd.2007.12.001 Gaspar, 2004, CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: do they indicate susceptibility to chronic obstructive pulmonary disease and non-small-cell lung cancer?, Genet. Mol. Biol., 27, 133, 10.1590/S1415-47572004000200001 Gattas, 2006, Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer, Head Neck, 28, 819, 10.1002/hed.20410 Go, 2015, Cytochrome P450 1 family and cancers, J. Steroid Biochem. Mol. Biol., 147, 24, 10.1016/j.jsbmb.2014.11.003 Gonzalez, 2004, Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility, Rev. Biol. Trop., 52, 591 Guilhen, 2009, Role of the N-Acetyltransferase 2 Detoxification system in thyroid cancer susceptibility, Clin. Cancer Res., 15, 406, 10.1158/1078-0432.CCR-08-1835 Han, 2013, Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk, Am. J. Epidemiol., 178, 493, 10.1093/aje/kwt016 He, 2014, Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case–control studies, Gene, 534, 324, 10.1016/j.gene.2013.10.025 Honma, 2009, Polymorphism of the CYP1A1*2A gene and susceptibility to lung cancer in a Brazilian population, J. Bras. Pneumol., 35, 767, 10.1590/S1806-37132009000800008 Imberger, 2015, Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection, Anesth. Analg., 121, 1611, 10.1213/ANE.0000000000000892 Ishibe, 1997, Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans, Cancer Epidemiol. Biomark. Prev., 6, 1075 Juarez-Cedillo, 2007, The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism, Eur. J. Cancer, 43, 1590, 10.1016/j.ejca.2007.03.025 Lee, 2006, Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers, Rev. Med. Chil., 134, 1107 Li, 2014, Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis, Tumour Biol., 35, 9281, 10.1007/s13277-014-2212-6 Lima, 2008, Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients, Folia Biol. (Praha)., 54, 102 Lopez-Cima, 2012, Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias, BMC Cancer, 12, 433, 10.1186/1471-2407-12-433 Losi-Guembarovski, 2008, Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population, Anticancer Res., 28, 1023 Lourenco, 2011, CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma, Tumour Biol., 32, 1209, 10.1007/s13277-011-0224-z Lu, 2015, Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis, Onco Targets Ther., 8, 2883, 10.2147/OTT.S92259 Martins de Oliveira, 2015, Association of CYP1A1 A4889G and T6235C polymorphisms with the risk of sporadic breast cancer in Brazilian women, Clinics, 70, 680, 10.6061/clinics/2015(10)04 McClean, 2011, A case-control study of asphalt and tar exposure and lung cancer in minorities, Am. J. Ind. Med., 54, 811, 10.1002/ajim.21007 Miller, 1978, The inverse of the freeman – Tukey double arcsine transformation, Am. Stat., 32, 138 Moreno-Estrada, 2014, Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits, Science, 344, 1280, 10.1126/science.1251688 Moreno-Galvan, 2010, Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study, Int. J. Biol. Markers, 25, 157, 10.1177/172460081002500306 Perez-Morales, 2014, Genetic susceptibility to lung cancer based on candidate genes in a sample from the Mexican Mestizo population: a case-control study, Lung, 192, 167, 10.1007/s00408-013-9536-7 Quiñones, 1995, Induction of rat hepatic P4501A1 by organic extracts from airborne particulate matter in Santiago, Chile, Xenobiotica, 25, 81, 10.3109/00498259509061835 Quinones, 2001, CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people, Cancer Lett., 174, 35, 10.1016/S0304-3835(01)00686-3 Rahal E, 2013, Frecuencia de los polimorfismos CYP1A1*2A y deleción del gen GSTM1 en pacientes con carcinoma de células escamosas de laringe en relación al hábito tabáquico: Estudio piloto en Chile, Rev. Otorrinolaringol Cir. Cabeza Cuello, 73, 7, 10.4067/S0718-48162013000100002 Recio-Vega, 2013, Potentially estrogenic polychlorinated biphenyls congeners serum levels and its relation with lung cancer, J. Appl. Toxicol., 33, 906, 10.1002/jat.2763 Reis, 2010, Involvement of CYP1A1, GST, 72TP53 polymorphisms in the pathogenesis of thyroid nodules, Genet. Mol. Res.: GMR., 9, 2222, 10.4238/vol9-4gmr807 Shimada, 2009, Genetic polymorphisms in estrogen metabolism and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians, J. Hum. Genet., 54, 209, 10.1038/jhg.2009.13 Siegel, 2015, Cancer statistics for Hispanics/Latinos, 2015, CA Cancer J. Clin., 65, 457, 10.3322/caac.21314 Sugimura, 1995, CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil, Pharmacogenetics, 5 Spec No, S145, 10.1097/00008571-199512001-00017 Swinney, 2011, Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children, Cancer Epidemiol. Biomark. Prev., 20, 1537, 10.1158/1055-9965.EPI-10-1265 Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, C. G. (2011) User Manual for Trial Sequential Analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark. www.ctu.dk/tsa Torresan, 2008, Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes, Clin. Exp. Med., 8, 65, 10.1007/s10238-008-0159-x Tsuchiya, 2010, Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women, Int. J. Biol. Markers, 25, 75, 10.1177/172460081002500203 Varela-Lema, 2008, Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review, Genet. Med., 10, 369, 10.1097/GIM.0b013e3181770196 Wang, 2015, Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis, BMC Med. Genet., 16, 25, 10.1186/s12881-015-0168-z Wells, 2011 Wrensch, 2005, CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans, Int. J. Cancer, 113, 141, 10.1002/ijc.20537 Wu, 2013, MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis, PLoS One, 8, 10.1371/journal.pone.0085166 Xia, 2013, Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis, Tumour Biol., 34, 223, 10.1007/s13277-012-0542-9 Xue, 2014, The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis, Tumour Biol., 35, 4741, 10.1007/s13277-014-1620-y Yamaguti, 2009, High risk of ‘de novo’ acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects, Eur. J. Haematol., 83, 270, 10.1111/j.1600-0609.2009.01272.x Yamaguti, 2010, Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H:quinone oxidoreductase 1 (NQO1)-inherited gene variants, Acta Haematol., 124, 182, 10.1159/000320275 Zhan, 2011, CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review, J. Exp. Clin. Cancer Res., 30, 99, 10.1186/1756-9966-30-99 Zhuo, 2012, CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects, J. Exp. Clin. Cancer Res., 31, 62, 10.1186/1756-9966-31-62 Zhuo, 2012, Quantitative assessment of CYP1A1*2A variations with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controls, Cancer Investig., 30, 552, 10.3109/07357907.2012.716470